Accuray Inc (FRA:XEJ)
€ 1.63 -0.08 (-4.68%) Market Cap: 159.89 Mil Enterprise Value: 296.36 Mil PE Ratio: 0 PB Ratio: 4.18 GF Score: 66/100

Accuray Inc At ASTRO Transcript

Oct 24, 2022 / 08:30PM GMT
Release Date Price: €2.03 (+6.44%)
Suzanne Winter
Accuray Incorporated - President, CEO & Director

Everyone who's on Zoom as well and joining this session. We have a very rich agenda today where we're going to hear from key opinion leaders -- hi, Marie, who will be talking a little bit about innovation and the future of radiation therapy over the coming years.

So you can see from the agenda overall, we're going to start out with Dr. Jean-Philippe Pignol, who's our Global Chief Medical Officer, Chief Technology Officer. He'll be talking a little bit about clinical evidence. And then we're going to go into 3 different care areas and prostate breast and neurological indications.

For prostate, we have Dr. Peter Orio, who's here with us. He's the Vice Chair of Radiation Oncology for Dana-Farber at Brigham and Women's. We also have Matthew Witten. He's our Chief Physicist, Department of Radiation Oncology and Director of the CyberKnife Radiosurgery at NYU Langone. Then when we're talking about breast, we have Frank Vicini, who's the National Principal Investigator at GenesisCare Oncology, as well as Brian Collins,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot